The Global Market for qPCR and dPCR Instrumentation is Projected to Reach US$4.9 Billion by 2024
Growing Demand for Genetic
and Genomic Analysis to Drive the Global qPCR and dPCR Instrumentation Market,
According to a New Report by Global Industry Analysts, Inc.
GIA
launches comprehensive analysis of industry segments, trends, growth drivers,
market size, share and demand forecasts on the global qPCR and dPCR
Instrumentation market. The global market for qPCR
and dPCR Instrumentation is projected to reach US$4.9 billion by 2024, driven by growing
geriatric population, rising incidence of genetic disorders, and rising
investment in gene therapy and research.
Polymerase
Chain Reaction (PCR) technology, an integral part of modern-day biology, is a
technique used in amplifying DNA sequence and producing several copies of a
particular DNA sequence. PCR is witnessing significant use in pharmaceutical
research and diagnostic applications, including diagnosis of various diseases,
development of novel therapies, profiling and forensics among others. PCR
continues to dominate the global gene amplification technologies market,
supported by roll out of several novel PCR instruments. The market for qPCR and
dPCR instrumentation and reagents is expected to witness significant growth driven
by increasing demand for genetic and genomic analysis in various end-use
markets alongside other factors. Factors encouraging growth in the qPCR instruments and reagents market include the
increasing availability of high-strength assays, higher demand for more
throughput, access to inexpensive equipment, automation and multiplexed
analytical strategies.
Real-time
PCR (RT-PCR)/quantitative PCR (qPCR) represents the leading
technology segment, with a wide ranging applications, ranging from academic
research, disease diagnosis, and pharmacogenomics, to water and food quality
testing and industrial microbiology. Digital PCR (dPCR), a relatively new
technology, facilitates absolute quantification of nucleic acid sequences and
provides higher accuracy and sensitivity when compared to qPCR. The widening
application base for dPCR, alongside constant technical advancements in both
chip and droplet dPCR, are expected to propel the
market forward. However, certain technical limitations of qPCR and dPCR coupled
with expensive nature of sophisticated PCR devices remain a major barrier to
broader adoption of these technologies. Technological refinement is also a
major driving factor, which is expected to continue into the near future. Technological
advancements are giving rise to improved versions of qPCR and dPCR systems and
consumables. Notable advancements including automation of the instruments,
which made real-time analysis simpler and expand their applications, integrated
systems that perform multiple tasks such as from preparation of sample through
analysis, and inclusion of droplet technology in dPCR among others.
As
stated by the new market research report on qPCR and dPCR
Instrumentation, the U.S. represents the largest market worldwide. Presence of
numerous pharmaceutical firms in the country employing PCR testing to diagnose
diseases and develop novel drugs along with growing investments into genetic
research, aging population and others result in high demand for qPCR and dPCR
instruments and reagents. However, Asia-Pacific represents the fastest growing
market worldwide, with a CAGR of 6.9% through the analysis period. Increase in
government and consumer per-capita spending on healthcare, expanding healthcare
needs compounded by the medical tourism trend and the ensuing need to improve
the quality of diagnosis and treatment are the major factors driving growth.
Major
players in the market include Agilent Technologies, Inc., Becton, Dickinson and
Company, BioFire Diagnostics, Inc., Bio-Rad Laboratories, Inc., Cepheid,
Eppendorf AG, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Promega
Corporation, QIAGEN N.V., RainDance Technologies, Inc., Takara Bio, Inc., and
Thermo Fisher Scientific Inc. among others.
The
research report titled “qPCR and dPCR
Instrumentation: A Global Strategic Business Report” announced by Global
Industry Analysts Inc., provides a comprehensive
review of market trends, issues, drivers, mergers, acquisitions and other
strategic industry activities of global companies. The report provides market
estimates and projections for qPCR and dPCR Instrumentation in value terms for
all major geographic markets such as United States, Canada, Japan, Europe
(France, Germany, Italy, UK and Rest of Europe), Asia-Pacific (China and Rest
of Asia-Pacific), Middle East & Africa, and Latin America. The report also
analyzes the global and regional markets for qPCR and dPCR Instrumentation by
the Product Categories - Reagents and Instruments. Product segments analyzed
include qPCR and dPCR. The report also analyzes the global qPCR and dPCR
Instrumentation market by the end-use segments Educational/Research, Testing
Laboratories and Pharma.
For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com
Global
Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights
Reserved.
Comments
Post a Comment